Research programme: mGlu2 positive allosteric modulators - Adamed
Latest Information Update: 08 Jan 2014
At a glance
- Originator Adamed
- Mechanism of Action Metabotropic glutamate receptor 2 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Anxiety disorders
Most Recent Events
- 08 Jan 2014 Early research in Anxiety disorders in Poland (unspecified route)
- 08 Jan 2014 Research programme: mGlu2 positive allosteric modulators - Adamed is available for licensing as of 08 Jan 2014. http://www.adamed.com.pl